Hyderabad (Telangana) [India], November 23: STAR Hospitals is proud to announce the official launch of the STAR Liver Institute at its Nanakramguda campus in Hyderabad. The institute, dedicated to advanced liver care and transplantation, was inaugurated today by SS Rajamouli, renowned filmma
According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether individuals with hepatocellular carcinoma, a kind of liver cancer, may benefit from immunotherapy.
A new study from the University of Pittsburgh School of Pharmacy provides light on the processes that contribute to liver fibrosis and proposes a unique therapy method for this prevalent and serious disorder.
Coimbatore (Tamil Nadu) [India], August 31: The liver experts at Sri Ramakrishna Hospital recognize the silent emergency of alcohol induced liver problems, offering insights to this extremely preventable condition. The Hepatology Department at Sri Ramakrishna Hospital is well-equipped to dia
Despite being preventable and treatable, these chronic infections are increasingly causing serious illness and deaths from liver cancer, cirrhosis, and liver failure in the region
A few years ago, Radha suffered from liver failure. She was diagnosed with the rare disease Wilson's, and ever since then, she has battled with the aberrant accumulation of copper in her organs, particularly her liver, hepatitis A dealt a deadly blow to her already damaged liver, leading to
Liver inflammation, a typical side effect of malignancies elsewhere in the body, has long been associated with poor cancer outcomes and, more recently, with poor response to immunotherapy. A team of researchers from the University of Pennsylvania's Abramson Cancer Centre and Perelman School
Researchers found out how chronic infection with the hepatitis B virus (HBV) causes gradual liver damage, and eradicating the virus remains a daunting challenge.
The report, released at the World Hepatitis Summit, highlights that despite better tools for diagnosis and treatment, and decreasing product prices, testing and treatment coverage rates have stalled.
Indian Immunologicals Ltd. (IIL), a wholly-owned subsidiary of the National Dairy Development Board (NDDB) and a biopharmaceutical company in India, launched India's first indigenously developed Hepatitis A vaccine, 'Havisure'.